Therapeutic applications of hyaluronan
- PMID: 20174672
- DOI: 10.1039/b910552m
Therapeutic applications of hyaluronan
Abstract
Hyaluronan (HA), a multifunctional, high molecular weight glycosaminoglycan, is a component of the majority of extracellular matrices. HA is synthesised in a unique manner by a family of hyaluronan synthases, degraded by hyaluronidases and exerts a biological effect by binding to families of cellular receptors, the hyaladhedrins. Receptor binding activates signal pathways in endothelial cells leading to proliferation, migration and differentiation collectively termed angiogenesis. HA and associated enzymes are implicated in the aetiology of cardiovascular disease and cancer and manipulation of HA expression offers a therapeutic target. HA microspheres have been developed as drug delivery agents to deliver HA to sites of disease and also in diagnosis. In this review we discuss some of the recent therapeutic applications of hyaluronan in tissue repair, as a drug delivery system and the synthesis, application and delivery of hyaluronan nanoparticles to target drugs to sites of disease.
Similar articles
-
An insight on hyaluronic acid in drug targeting and drug delivery.J Drug Target. 2008 Feb;16(2):91-107. doi: 10.1080/10611860802095494. J Drug Target. 2008. PMID: 18274931 Review.
-
Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.Gynecol Oncol. 2005 Aug;98(2):193-202. doi: 10.1016/j.ygyno.2005.02.031. Gynecol Oncol. 2005. PMID: 15936804
-
Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells.Biomaterials. 2006 May;27(15):2994-3004. doi: 10.1016/j.biomaterials.2006.01.020. Epub 2006 Feb 2. Biomaterials. 2006. PMID: 16457881
-
A review of hyaluronan and its ophthalmic applications.Optometry. 2011 Jan;82(1):38-43. doi: 10.1016/j.optm.2010.08.003. Optometry. 2011. PMID: 21146792 Review.
-
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects.Skin Pharmacol Physiol. 2004 Sep-Oct;17(5):207-13. doi: 10.1159/000080213. Skin Pharmacol Physiol. 2004. PMID: 15452406 Review.
Cited by
-
A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues.PLoS One. 2014 Jan 20;9(1):e84287. doi: 10.1371/journal.pone.0084287. eCollection 2014. PLoS One. 2014. PMID: 24465401 Free PMC article.
-
Hyaluronan regulation of vascular integrity.Am J Cardiovasc Dis. 2011;1(3):200-13. Epub 2011 Sep 10. Am J Cardiovasc Dis. 2011. PMID: 22254199 Free PMC article.
-
Efficacy and Tolerability of Hybrid Complexes of High- and Low-Molecular-Weight Hyaluronan Intradermal Injections for the Treatment of Skin Roughness and Laxity of the Neck.ScientificWorldJournal. 2022 Sep 17;2022:4497176. doi: 10.1155/2022/4497176. eCollection 2022. ScientificWorldJournal. 2022. PMID: 36164489 Free PMC article.
-
Hyaluronan Dermal Fillers: Efforts Towards a Wider Biophysical Characterization and the Correlation of the Biophysical Parameters to the Clinical Outcome.Clin Cosmet Investig Dermatol. 2020 Jan 28;13:87-97. doi: 10.2147/CCID.S220227. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 32095081 Free PMC article.
-
Gastroesophageal reflux disease in children: What's new right now?World J Gastrointest Endosc. 2023 Mar 16;15(3):84-102. doi: 10.4253/wjge.v15.i3.84. World J Gastrointest Endosc. 2023. PMID: 37034973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources